Actively Recruiting
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
Led by Rutgers, The State University of New Jersey · Updated on 2026-04-16
176
Participants Needed
2
Research Sites
76 weeks
Total Duration
On this page
Sponsors
R
Rutgers, The State University of New Jersey
Lead Sponsor
N
NYU Langone Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study aims to answer is: 1. Can a once daily dose of long-acting insulin control blood sugars as well as long-acting insulin plus meal-time insulin? 2. Do babies born to mothers who take one dose of long-acting insulin have more complications after birth than babies born to mothers who take long-acting and meal-time insulin? Researchers will compare one dose of long-acting insulin per day to this plus three doses of short-acting insulin with each meal to see if blood sugars are controlled. Participants will send their blood sugar logs to the study staff weekly, instead of to their OB/GYN, for adjustments to their insulin dosing.
CONDITIONS
Official Title
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with type 2 diabetes mellitus or A2 gestational diabetes mellitus requiring insulin use during pregnancy
- Aged between 18-50
- Speak English or Spanish
You will not qualify if you...
- Pre-existing use of insulin
- Gestational age greater than or equal to 35 weeks 0 days
- Planning to follow-up with a doctor not associated with RWJ Barnabas or NYU Langone Health and/or deliver at a hospital other than RWJUH or NYU
- Unwilling or unable to upload or email weekly blood sugar logs
- Contraindication to Lispro or Lantus insulin, or patient chooses not to use insulin therapy
- Fetal anomaly present
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Robert Wood Johnson Univeristy Hospital
New Brunswick, New Jersey, United States, 08901
Actively Recruiting
2
Maternal-Fetal Medicine at NYU Langone Obstetrics & Gynecology Associates
New York, New York, United States, 10022
Not Yet Recruiting
Research Team
M
Morgan Dunn, MD
CONTACT
E
Emily Rosenfeld, DO
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here